arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

PepGen Inc.

PEPG Health Care Biotechnology: Pharmaceutical Preparations
$2.52
▼ -7.3% Today
as of Oct 23, 16:51 ET
Last 30 days -15.15% Sep 14 → Oct 23
$2.15 $2.37 $2.60 $2.82 $3.04 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$2.80
High
$2.80
Low
$2.44
Volume
$1M
Avg Vol
$975,657
Mkt Cap
$153M
P/E (TTM)
—
Beta
—
52w High
$7.80
52w Low
$1.31
Div Yield
—
Shares Out
—

PEPG earnings at a glance

The options market is pricing a move of about ±42.5% after the report, a range of roughly $1.45 to $3.59 from today's $2.52. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±11.7% on average; after the most recent report on May 12, 2026 it moved -1.2%. That means options currently expect more movement than PEPG has typically delivered. PEPG beat the consensus EPS estimate in 3 of its last 4 reported quarters. Implied volatility is currently 240%. The share price of $2.52 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.31
$7.80
19% of range
Avg surprise (last 4)
+5.9%
Avg reaction (last 2)
+10.5%
50% positive
Latest IV / EM
240%
EM ±42.5% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.98$-0.80$-0.62$-0.44$-0.26 Actual $-0.69Actual $-0.82Actual $-0.98Actual $-0.63Actual $-0.87Actual $-0.66Actual $-0.92Est $-0.72Actual $-0.70Est $-0.85Actual $-0.52Est $-0.63Actual $-0.26Est $-0.31Actual $-0.26 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-30M$-27M$-24M$-22M$-19M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.26 — — — — financials
Tue May 12, 2026Mar/2026 $-0.26 $-0.31 +16.1% +71.7% -1.2% earnings
Wed Nov 12, 2025Sep/2025 $-0.52 $-0.63 +17.5% — — earnings
Thu Aug 7, 2025Jun/2025 $-0.70 $-0.85 +17.6% — — earnings
Thu May 8, 2025Mar/2025 $-0.92 $-0.72 -27.8% — +22.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.66 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.87 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.63 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.98 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.82 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.69 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-19M$-19M—$-19M$-24M$-31M—$-23M
Net income$-18M$-18M—$-18M$-23M$-30M—$-21M
EPS (diluted)$-0.26$-0.26—$-0.52$-0.70$-0.92—$-0.66

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$23M$42M$61M$143M$35M$44M$49M$42M
Inventory————————
Total current assets$120M$134M$151M$166M$77M$101M$124M$142M
Total assets$141M$156M$174M$190M$102M$127M$151M$170M
Long-term debt————————
Total liabilities$22M$22M$26M$27M$31M$36M$32M$33M
Total equity$120M$134M$147M$163M$71M$92M$119M$137M

Implied volatility — last 90 days

56%279%502%724%947% Jun 24 — IV 310% · EM ±62.1%Jul 01 — IV 366% · EM ±61.1%Jul 09 — IV 331% · EM ±39.1%Jul 10 — IV 348% · EM ±38.5%Jul 13 — IV 613% · EM ±51.2%Jul 14 — IV 510% · EM ±36.9%Jul 15 — IV 635% · EM ±37.5%Jul 16 — IV 811% · EM ±33.9%Jul 21 — IV 223% · EM ±51.9%Jul 31 — IV 327% · EM ±62.5%Aug 07 — IV 113% · EM ±17.7%Aug 10 — IV 144% · EM ±20.0%Aug 11 — IV 117% · EM ±15.5%Aug 12 — IV 110% · EM ±13.8%Aug 13 — IV 58% · EM ±6.8%Aug 18 — IV 143% · EM ±10.3%Aug 19 — IV 110% · EM ±6.5%Aug 20 — IV 157% · EM ±6.6%Aug 24 — IV 75% · EM ±15.7%Aug 26 — IV 117% · EM ±23.4%Aug 27 — IV 57% · EM ±11.3%Aug 28 — IV 110% · EM ±21.1%Aug 31 — IV 56% · EM ±10.0%Sep 01 — IV 128% · EM ±22.0%Sep 09 — IV 228% · EM ±28.6%Sep 15 — IV 167% · EM ±12.1%Sep 21 — IV 160% · EM ±33.5%Sep 22 — IV 98% · EM ±20.1%Sep 23 — IV 532% · EM ±106.6%Sep 24 — IV 948% · EM ±185.7%Sep 25 — IV 136% · EM ±26.1%Sep 28 — IV 240% · EM ±42.5%

Sector peers

ASRT
Assertio Holdings, Inc.
$151M $23.50
OGI
Organigram Global Inc.
$169M $0.93-1.6%
PMVP
PMV Pharmaceuticals, Inc.
$132M $1.27-6.6%
CNTN
Canton Strategic Holdings, Inc.
$174M $1.86-3.6%
SPRB
Spruce Biosciences, Inc.
$129M $45.15+5.7%
NKTX
Nkarta, Inc.
$183M $1.79+2.3%

PEPG earnings FAQ

What is PEPG's expected move for earnings?

Options currently price a move of about ±42.5%, or $1.07 per share either way from $2.52.

How does PEPG stock usually react to earnings?

Across the last 2 reports the average next-day move was ±11.7%, up 1 times and down 1 times.

What is PEPG's implied volatility?

PEPG's at-the-money implied volatility is about 240% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in